TD Cowen cut Strategy’s 12-month price target from $500 to $440 because issuing more shares will dilute Bitcoin per share.TD Cowen cut Strategy’s 12-month price target from $500 to $440 because issuing more shares will dilute Bitcoin per share.

TD Cowen cuts Strategy Bitcoin price target to $440

4 min read

Investment bank TD Cowen analysts have revised their pricing prediction for Strategy, estimating it would be $440, down from their previous estimate of $500. 

They changed the plan because they believe the company’s methods of acquiring more Bitcoin could ultimately result in each share of the company being worth a little less. 

Strategy is acquiring Bitcoin quicker than the majority of analysts expected. It is now projected to acquire around 155,000 Bitcoins in fiscal 2026, up from 90,000. It intends to fund that accelerated acquisition by issuing more common shares and preferred stock. When a company sells more shares, each existing share represents a smaller piece of the company—a process called dilution—which can reduce the amount of Bitcoin attributed to each share and, in turn, its value

The analysts calculated that in 2026, the firm’s “Bitcoin yield” will be 7.1%. This is lower than their previous estimate of 8.8%, and much lower than the 22.8% yield in 2025. In simple terms, even though the company will get more Bitcoin, each share will benefit a little less because more shares are being issued.

Strategy snaps up Bitcoin while prices drop

Even though Bitcoin prices have been lower recently, Strategy has not slowed down. The company has been using the dip in Bitcoin prices to buy more. For example, in the week ending January 11, 2026, the firm sold approximately 6.8 million shares of its regular stock and 1.2 million shares of its special preferred stock, designated as STRC. This raised around $1.25 billion. Nearly all of this money was used to buy an extra 13,627 Bitcoins.

The analysts said that many people might have expected Strategy to slow down, since the company’s Bitcoin price seemed very low. But Strategy chose to continue buying aggressively. The analysts believe the company made this decision because they expect Bitcoin prices to go up again in the future.

Because most of these new Bitcoin purchases were funded by selling shares close to their current value, they did not increase the “Bitcoin yield” much. In other words, while the company bought more Bitcoins, the benefit for each share was small.

The analysts believe this strategy only works if Bitcoin prices rise, which they consider likely due to improved regulations from governments and stronger economic conditions.

Strategy drives growth and prepares for bigger Bitcoin gains

TD Cowen’s analysts expect Strategy to keep selling shares and preferred stock as long as Bitcoin prices stay low. They predict that by December 2026, the price of Bitcoin could reach around $177,000. By December 2027, the price is expected to increase to approximately $226,000. As prices rise, the Bitcoin yield per share is expected to improve in 2027, meaning each share will represent a greater value of Bitcoin again.

Even though the analysts lowered the price target and expect a smaller Bitcoin yield in the short term, they still think Strategy is a good way for people to invest in Bitcoin. They said the company’s preferred stocks could provide investors with both income and the opportunity to make a profit if the stock price increases. For example, they highlighted the senior STRF preferred shares, which could offer a return of approximately 30%.

The analysts also mentioned news about MSCI, a company that makes indexes for investors. MSCI recently decided not to remove Bitcoin treasury companies, such as Strategy, from its indexes. This is good news for Strategy in the near term. However, the analysts cautioned that uncertainty could persist in the future. They explained that big investors, such as BlackRock, make a significant amount of money from Bitcoin investment products, and sometimes these investors may view companies like Strategy as competitors. This could influence decisions by index makers in the long term.

Join a premium crypto trading community free for 30 days - normally $100/mo.

Market Opportunity
Moonveil Logo
Moonveil Price(MORE)
$0.0007811
$0.0007811$0.0007811
-1.77%
USD
Moonveil (MORE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

FCA komt in 2026 met aangepaste cryptoregels voor Britse markt

FCA komt in 2026 met aangepaste cryptoregels voor Britse markt

De Britse financiële waakhond, de FCA, komt in 2026 met nieuwe regels speciaal voor crypto bedrijven. Wat direct opvalt: de toezichthouder laat enkele klassieke financiële verplichtingen los om beter aan te sluiten op de snelle en grillige wereld van digitale activa. Tegelijkertijd wordt er extra nadruk gelegd op digitale beveiliging,... Het bericht FCA komt in 2026 met aangepaste cryptoregels voor Britse markt verscheen het eerst op Blockchain Stories.
Share
Coinstats2025/09/18 00:33
Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26
Trump foe devises plan to starve him of what he 'craves' most

Trump foe devises plan to starve him of what he 'craves' most

A longtime adversary of President Donald Trump has a plan for a key group to take away what Trump craves the most — attention. EX-CNN journalist Jim Acosta, who
Share
Rawstory2026/02/04 01:19